Amneal Pharmaceuticals (STU:2DT) Short-Term Debt : €196 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Amneal Pharmaceuticals Short-Term Debt?

Amneal Pharmaceuticals's Short-Term Debt for the quarter that ended in Mar. 2024 was €196 Mil.

Amneal Pharmaceuticals's quarterly Short-Term Debt increased from Sep. 2023 (€100 Mil) to Dec. 2023 (€195 Mil) and increased from Dec. 2023 (€195 Mil) to Mar. 2024 (€196 Mil).

Amneal Pharmaceuticals's annual Short-Term Debt increased from Dec. 2021 (€27 Mil) to Dec. 2022 (€85 Mil) and increased from Dec. 2022 (€85 Mil) to Dec. 2023 (€195 Mil).

Amneal Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for Amneal Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amneal Pharmaceuticals Short-Term Debt Chart

Amneal Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

19.33

37.18

27.09

84.92

195.44

Amneal Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															121.39	138.82	99.82	195.44	195.65

Amneal Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Amneal Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Amneal Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Amneal Pharmaceuticals (STU:2DT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amneal Pharmaceuticals Inc (STU:2DT) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

AMRX:USA 2DT:Germany

Address

400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ, USA, 08807

Website

https://www.amneal.com

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.

Amneal Pharmaceuticals (STU:2DT) Headlines

No Headlines